Stocks
Cyabra Announces Pricing of $6.0 Million Private Placement Priced At a Premium to the Market Price with New and Existing Institutional Investors, Management, and Board Members
In conjunction with the Private Placement, all outstanding preferred shares will convert into common stock or common stock equivalents in lieu thereof, subject to stockholder approval An existing shareholder, as well as management and board members, are investing new equity as part of the Private Placement New York, NY, July 09, 2026 (GLOBE NEWSWIRE) -- Cyabra, Inc. (Nasdaq: CYAB) ("Cyabra" or the "Company"), a company whose artificial intelligence ("AI")-powered platform helps governments and e
About this update from Cyabra, Inc.
New York, NY, July 09, 2026 (GLOBE NEWSWIRE) -- Cyabra, Inc. (Nasdaq: CYAB) ("Cyabra" or the "Company"), a company whose artificial intelligence ("AI")-powered platform helps governments and enterprises detect coordinated manipulation and protect digital trust, today announced that it has entered into securities purchase agreements with new and existing institutional investors, management, and board members, for the purchase and sale of 13,818,770 shares of common stock (or common stock equivalents in lieu thereof), Series A Warrants to purchase up to 13,818,770 shares of common stock (the "Series A Warrants") and Series B Warrants to purchase up to 13,818,770 shares of common stock (the "Series B Warrants," and together with the Series A Warrants, the "Warrants") at a combined purchase price of $0.435 per share and accompanying Warrants in a private placement (the "Private Placement"). The gross proceeds from the Private Placement offering are expected to be approximately $6.0 million, before deducting placement agent commissions and other estimated offering expenses. The Series A Warrants will have an exercise price of $0.50 per share, will be initially exercisable on the date stockholder approval is obtained, and will expire five years from the initial exercise date. The Series B Warrants will have an exercise price of $0.45 per share, will be initially exercisable on the date stockholder approval is obtained, and will expire twelve months from the initial exercise date. In connection with the offering, the Company and its existing holders of the Company's Series A Convertible Preferred Stock and Series B Convertible Preferred Stock have agreed to amend the conversion price of the preferred shares to $0.435 and convert all outstanding preferred shares into an aggregate of 35,648,276 shares of common stock (or common stock equivalents in lieu thereof) (the "Preferred Conversion"). In addition, the holder of the Company's Series C Convertible Preferred Stock agreed to exchange its preferred stock having an aggregate value of $10,660,000 for the securities sold in the Private Placement (the "Exchange"). The Preferred Conversion and the Exchange are subject to stockholder approval.